The results showed that in high risk patients with T2D liraglutide reduced the risk of MACE by 13% (primary endpoint included cardiovascular death, non-fatal myocardial infarction (MI), and non-fatal stroke) ( In the ELIXA and the EXSCEL trials, GLP-1RAs (once daily lixisenatide and once weekly exenatide, respectively) didnt provide benefit in MACE reduction compared to placebo, but were non-inferior to placebo for the primary composite outcome of MACE
Supports Muscle Recovery & Performance: L-Glutamine is a key amino acid that promotes post-workout muscle recovery and helps reduce soreness, making it ideal for athletes, active individuals, and anyone looking to maintain lean muscle and performance levels
Trial data have shown decreases in serious cardiovascular complications, including cardiovascular mortality, nonlethal heart attacks, and nonfatal cerebrovascular accidents, among individuals with type 2 diabetes and pre-existing cardiovascular pathology or high cardiovascular risk [3,5,13,14,37]
In terms of beauty, weight loss from GLP-1 is known to have a physical impact on the face and skin, causing sagging or sunken effects